Thus, a current smoker with high inflammatory cytokine concentration, i.e., baseline IL-6, high tumor burden, and more advanced disease stage, would have a 68.3-fold faster CRP production rate and consequently a higher, unfavorable inflammatory level than a non-smoker with low inflammatory response, low tumor burden, and less advanced disease stage. Here, CRP is linked to neoplasm.